Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-04 Sale |
2025-03-06 4:27 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
3,445 | $6.29 | $21,669 | 34,314 (Direct) |
View |
| 2024-09-04 Sale |
2024-09-05 4:13 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
5,356 | $0.7218 | $3,866 | 404,051 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 7:37 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
26,949 | $1.1757 | $31,684 | 393,509 (Direct) |
View |
| 2023-09-01 Sale |
2023-09-05 4:27 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
7,415 | $1.3313 | $9,872 | 204,086 (Direct) |
View |
| 2023-06-08 Sale |
2023-06-12 4:07 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
1,839 | $2.35 | $4,322 | 211,501 (Direct) |
View |
| 2023-03-01 Sale |
2023-03-02 5:33 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
11,239 | $3.0292 | $34,045 | 210,687 (Direct) |
View |
| 2022-06-13 Sale |
2022-06-14 7:25 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan Chief Commercial Officer |
1,551 | $5.2062 | $8,075 | 89,949 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-28 Option Award |
2025-03-04 4:54 pm |
N/A 2035-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
29,998 | $0 | 57,758 (Direct) |
View |
| 2024-10-31 Option Award |
2024-11-01 4:31 pm |
N/A 2034-10-31 |
Carisma Therapeutics Inc. | CARM | Cheng Sohanya Roshan Director |
38,700 | $0 | 38,700 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-29 5:35 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
198,959 | $0 | 420,458 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 7:40 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
14,167 | $0 | 221,499 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 5:33 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
100,000 | $0 | 210,687 (Direct) |
View |
| 2022-08-31 Option Award |
2022-09-01 9:00 pm |
N/A 2032-08-30 |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
75,000 | $0 | 164,949 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:15 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan Chief Commercial Officer |
192,000 | $0 | 199,500 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-01 4:33 pm |
N/A 2031-06-29 |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan SVP Sales & Commercial Ops |
132,500 | $0 | 132,500 (Direct) |
View |